Articles published in
Clin Res Hepatol Gastroenterol
Retrieve available abstracts of 62 articles: HTML format
Single Articles
June 2025
BEN YEDDER N, Girot P, Koudougou C, Schnee M, et al Lack of prior screening for advanced liver fibrosis in patients with newly
diagnosed hepatocellular carcinoma: Results from a prospective multicentre study.
Clin Res Hepatol Gastroenterol. 2025;49:102607. PubMedAbstract available
GOYAL RM, Bansal B, Ayyad M, Singh A, et al Clinical outcomes in patients with autoimmune hepatitis and primary biliary
cholangitis overlap syndrome in the United States.
Clin Res Hepatol Gastroenterol. 2025;49:102598. PubMedAbstract available
May 2025
LEE CH, Kang MG, Oh S, Gwak IS, et al Hepatocellular carcinoma risk in ICD-coded non-cirrhotic nonalcoholic fatty liver
disease refined by fatty liver index: A nationwide South Korean cohort study.
Clin Res Hepatol Gastroenterol. 2025;49:102612. PubMedAbstract available
VILLAVICENCIO EA, Serdjebi C, Maldonado A, Ochoa Mora E, et al Use of Hepatoscope 2DTE for non-invasive assessment of liver stiffness among
Mexican immigrant adults in a community-based setting.
Clin Res Hepatol Gastroenterol. 2025;49:102581. PubMedAbstract available
April 2025
TATOUR M, Baker FA, Saadi T, Yahia A, et al Advancements in autoimmune hepatitis epidemiology, treatment and complication - a
15-year retrospective study.
Clin Res Hepatol Gastroenterol. 2025;49:102570. PubMedAbstract available
LANTHIER N, Spahr L Macrophage therapy and liver regeneration: Results and perspectives.
Clin Res Hepatol Gastroenterol. 2025;49:102569. PubMedAbstract available
March 2025
HE Y, Ye M, Xia Y, Zhong Z, et al The role of cytokines as predictors for NAFLD-related diseases: A bidirectional
Mendelian randomization study.
Clin Res Hepatol Gastroenterol. 2025;49:102545. PubMedAbstract available
ABDEL MONEM MS, Adel A, Abbassi MM, Abdelaziz DH, et al Efficacy and safety of dapagliflozin compared to pioglitazone in diabetic and
non-diabetic patients with non-alcoholic steatohepatitis: A randomized clinical
trial.
Clin Res Hepatol Gastroenterol. 2025;49:102543. PubMedAbstract available
February 2025
LIU Z, Yang X, Jiang H, Xie R, et al Advancements of direct oral anticoagulants in cirrhotic individuals with portal
vein thrombosis.
Clin Res Hepatol Gastroenterol. 2025 Feb 19:102553. PubMedAbstract available
January 2025
SASAKI M, Sato Y, Nakanuma Y A heterogeneous subtype of biliary epithelial senescence may be involved in the
pathogenesis of primary biliary cholangitis.
Clin Res Hepatol Gastroenterol. 2025;49:102512. PubMedAbstract available
November 2024
WANG Z, Wang Z, Li F, Cai J, et al Construction and Validation of a Machine Learning-Based Prediction Model for
Short-Term Mortality in Critically Ill Patients with Liver Cirrhosis.
Clin Res Hepatol Gastroenterol. 2024 Nov 30:102507. PubMedAbstract available
JIANG J, Bouquet E, Kweon Y, Elsaid MI, et al Neighborhood Opportunity is Associated with Completion of Hepatocellular
Carcinoma Surveillance Prior to the Diagnosis of Hepatocellular Carcinoma in
Patients with Cirrhosis.
Clin Res Hepatol Gastroenterol. 2024 Nov 1:102485. PubMedAbstract available
LEE YP, Chiu CC, Chang YC, Chen YH, et al Co-exposure to different bacterial species' lipopolysaccharides with the NASH
diet exacerbates NASH and liver fibrosis progression in mice.
Clin Res Hepatol Gastroenterol. 2024;48:102470. PubMedAbstract available
October 2024
ZHONG H, Lu S, Xu M, Liu N, et al Predictive value of hepatic venous pressure gradient in cirrhotic portal vein
thrombosis development.
Clin Res Hepatol Gastroenterol. 2024 Oct 29:102484. PubMedAbstract available
DING J, He X, Lin W, Xia S, et al Exploring the relationship between vitamin D and hepatic carcinoma in individuals
diagnosed with hepatitis B virus infection.
Clin Res Hepatol Gastroenterol. 2024;48:102457. PubMedAbstract available
CANCADO GGL, Fucuta PDS, Gomes NMF, Couto CA, et al Alkaline phosphatase and liver fibrosis at diagnosis are associated with deep
response to ursodeoxycholic acid in primary biliary cholangitis.
Clin Res Hepatol Gastroenterol. 2024;48:102453. PubMedAbstract available
WANG M, Liu X, Qiao C, Chen R, et al Association of congenital hepatic fibrosis and Caroli's syndrome: Two
illustrative cases.
Clin Res Hepatol Gastroenterol. 2024;48:102443. PubMed
KHONDE P, Choudhury S, Spies NC, Naz N, et al Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts
biochemical remission in autoimmune hepatitis.
Clin Res Hepatol Gastroenterol. 2024;48:102442. PubMedAbstract available
September 2024
HAO NB, Zhou Y, Zhang D, Li YN, et al Effect of sarcopenia on liver cirrhosis with complicating oesophageal and gastric
varices after endoscopic therapy.
Clin Res Hepatol Gastroenterol. 2024 Sep 10:102459. PubMedAbstract available
KURNIAWAN J, Siahaan BS Performance of Spleen Stiffness Measurement by 100-Hz Vibration-Controlled
Transient Elastography, Liver Stiffness, APRI Score and their Combination for
Predicting Oesophageal Varices in Liver Cirrhosis.
Clin Res Hepatol Gastroenterol. 2024 Sep 1:102456. PubMedAbstract available
August 2024
GANTZEL RH, Deleuran T, Vilstrup H, Watson H, et al The CIRrhotic Ascites Severity (CIRAS) model predicts hepatic hydrothorax at all
stages of ascites.
Clin Res Hepatol Gastroenterol. 2024;48:102452. PubMedAbstract available
EZHILARASAN D, Najimi M Quiescent hepatic stellate cell activation in liver fibrosis: Have we found the
right trigger yet?
Clin Res Hepatol Gastroenterol. 2024;48:102420. PubMed
HU T, Tang W, Hong W, Huang Q, et al Spermine oxidase regulates liver inflammation and fibrosis through beta-catenin
pathway.
Clin Res Hepatol Gastroenterol. 2024;48:102421. PubMedAbstract available
LIN YL, Yao T, Wang YW, Yu JS, et al Association between primary biliary cholangitis with diabetes and cardiovascular
diseases: A bidirectional multivariable Mendelian randomization study.
Clin Res Hepatol Gastroenterol. 2024;48:102419. PubMedAbstract available
LI R, Lee S, Rienas W, Sarin S, et al Higher risk of in-hospital mortality and hepatic encephalopathy during weekend
admission in Transjugular Intrahepatic Portosystemic Shunt procedure.
Clin Res Hepatol Gastroenterol. 2024;48:102396. PubMedAbstract available
JIANG R, Hua Y, Hu X, Hong Z, et al The pan immune inflammatory value in relation to non-alcoholic fatty liver
disease and hepatic fibrosis.
Clin Res Hepatol Gastroenterol. 2024;48:102393. PubMedAbstract available
HU J, Mi Y, Wang L, Jiang F, et al Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian
randomization in primary biliary cholangitis.
Clin Res Hepatol Gastroenterol. 2024;48:102394. PubMedAbstract available
RASHU EB, Werge MP, Hetland LE, Thing M, et al Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the
general population.
Clin Res Hepatol Gastroenterol. 2024;48:102389. PubMedAbstract available
FU H, Li H, Du Y, Liu C, et al Factors influencing pathological changes in the liver tissue in hepatitis B virus
carriers with low-level viremia.
Clin Res Hepatol Gastroenterol. 2024;48:102351. PubMedAbstract available
July 2024
BALE G, Clarembeau F, Starkel P, Dahlqvist G, et al Patients with chronic liver diseases are at risk for diabetes even before
development of cirrhosis.
Clin Res Hepatol Gastroenterol. 2024 Jul 22:102428. PubMedAbstract available
June 2024
OLIVEIRA M, Gaspar R, Santos L, Macedo G, et al High incidence of hepatocarcinoma in patients with advanced fibrosis treated with
direct-acting antiviral agents for hepatitis C: a real-world retrospective study.
Clin Res Hepatol Gastroenterol. 2024 Jun 18:102404. PubMedAbstract available
ROGALSKI J, Czarnecka-Chrebelska K, Weglewska K, Pleska K, et al Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric
inpatients.
Clin Res Hepatol Gastroenterol. 2024;48:102366. PubMed
TANAKA A, Corpechot C PPAR agonists in PBC: Where do we go from here? Or how to choose between the new
and the old.
Clin Res Hepatol Gastroenterol. 2024;48:102358. PubMedAbstract available
ZHOU F, Liu X, Chang C, Liu J, et al Separating the effects of early and later life body mass index on liver diseases:
A Mendelian randomization study.
Clin Res Hepatol Gastroenterol. 2024;48:102352. PubMedAbstract available
May 2024
MANSUR A, Grobman B, Lu CY Suicide risk is elevated among patients with chronic liver disease and cirrhosis
in the United States.
Clin Res Hepatol Gastroenterol. 2024;48:102378. PubMed
CHANG G, Sun J, Li J, Li T, et al Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic
Review and Meta-Analysis.
Clin Res Hepatol Gastroenterol. 2024 May 1:102361. PubMedAbstract available
LI R, Sarin S The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure:
A national inpatient sample analysis from 2015 to 2020.
Clin Res Hepatol Gastroenterol. 2024;48:102323. PubMedAbstract available
LIANG Y, Li J, Zhang Z, Jiang T, et al Extrahepatic conditions of primary biliary cholangitis: A systematic review and
meta-analysis of prevalence and risk.
Clin Res Hepatol Gastroenterol. 2024;48:102321. PubMedAbstract available
April 2024
PATEL K, Twohig P, Peeraphatdit T, Stohs EJ, et al Outcomes and factors associated with cryptococcal disease among cirrhotics: A
study of the national inpatient sample 2005 to 2014.
Clin Res Hepatol Gastroenterol. 2024;48:102337. PubMedAbstract available
February 2024
HE Q, Xiong Y, Xia P, Yang X, et al Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after
radiofrequency ablation by competing risk nomogram: A population-based analysis.
Clin Res Hepatol Gastroenterol. 2024;48:102283. PubMedAbstract available
XIE C, Liu K, Xie Y, Liu S, et al Metabolism-related signalling pathways involved in the pathogenesis and
development of metabolic dysfunction-associated steatotic liver disease.
Clin Res Hepatol Gastroenterol. 2024;48:102264. PubMedAbstract available
January 2024
KUMAR MS Paneth cell: The missing link between obesity, MASH and portal hypertension.
Clin Res Hepatol Gastroenterol. 2024;48:102259. PubMedAbstract available
SEXTON F, Shanahan W, Ryan JD Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary
cholangitis.
Clin Res Hepatol Gastroenterol. 2024;48:102255. PubMed
December 2023
THABUT D, Roux J, Simon-Sultanik P, Tamberou C, et al Population characteristics, healthcare pathways and outcomes of patients with
cirrhosis hospitalized with overt hepatic encephalopathy in France: a study of
the French Hospital-Discharge Database.
Clin Res Hepatol Gastroenterol. 2023 Dec 26:102274. PubMedAbstract available
JANG H, Han N, Staatz CE, Kwak JH, et al Effect on lipid profile and clinical outcomes of obeticholic acid for the
treatment of primary biliary cholangitis and metabolic dysfunction-associated
steatohepatitis: A systematic review and meta-analysis.
Clin Res Hepatol Gastroenterol. 2023;47:102227. PubMedAbstract available
JIANG R, Zhou Y, Han L, Hong Z, et al Serum vitamin D is associated with ultrasound-defined hepatic fibrosis.
Clin Res Hepatol Gastroenterol. 2023;47:102228. PubMedAbstract available
DONATI A, Henrion J, Regnier M, Deltenre P, et al Abstinence is associated with better outcomes in patients with alcohol-related
hepatocellular carcinoma: Results of an observational study.
Clin Res Hepatol Gastroenterol. 2023;47:102225. PubMedAbstract available
October 2023
CHAIBI S, Larrey E, Couty JP, Sultanik P, et al Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by
Atezolizumab-Bevacizumab for advanced HCC.
Clin Res Hepatol Gastroenterol. 2023;47:102199. PubMedAbstract available
DUMONT C, Lanthier N, Dahlqvist G Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short
review.
Clin Res Hepatol Gastroenterol. 2023;47:102194. PubMedAbstract available
September 2023
MARTINO VD, Questiaux J, Lemagoarou T, Weil D, et al Granulocyte Colony Stimulating Factor in decompensated cirrhosis, acute alcoholic
hepatitis, and acute-on-chronic liver failure: a comprehensive meta-analysis of
randomized controlled trials.
Clin Res Hepatol Gastroenterol. 2023 Sep 14:102207. PubMedAbstract available
KOUNIS I, Sacleux SC, Ordan MA, Andre S, et al Efficiency and safety of total plasma exchange in critically ill cirrhotic
patients with acute on chronic liver failure: A pilot study.
Clin Res Hepatol Gastroenterol. 2023;47:102206. PubMedAbstract available
August 2023
LU M, Zhu M, Li H, Wang Q, et al Factors associated with discordance in the assessment of fibrosis stage between
transient elastography and liver biopsy in NAFLD patients.
Clin Res Hepatol Gastroenterol. 2023;47:102183. PubMedAbstract available
MAMANDIPOOR B, Wernly S, Semmler G, Flamm M, et al Machine learning models predict liver steatosis but not liver fibrosis in a
prospective cohort study.
Clin Res Hepatol Gastroenterol. 2023;47:102181. PubMedAbstract available
CALLERI A, Alessandria C Renal damage in Hepatorenal Syndrome: A still unsolved issue.
Clin Res Hepatol Gastroenterol. 2023;47:102178. PubMedAbstract available
June 2023
WANG X, Xu GH, Yu J, Li H, et al When cirrhosis meets paroxysmal nocturnal hemoglobinuria: What kind of
"fireworks" scenario will occur?
Clin Res Hepatol Gastroenterol. 2023;47:102173. PubMed
May 2023
YAICI L, Gatouillat G, Andreoletti L, N'Guyen Y, et al Chronic Hepatitis Delta cirrhosis cured by adapting PEG-IFNalpha-2a + tenofovir
disoproxil fumarate treatment duration until HBsAg loss.
Clin Res Hepatol Gastroenterol. 2023 May 25:102148. PubMedAbstract available
RAVAIOLI F, Berger A, Farcau O, Colecchia A, et al Individual and population screening of varices needing treatment by a simple,
safe and accurate test.
Clin Res Hepatol Gastroenterol. 2023;47:102123. PubMedAbstract available
MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting
CREST syndrome.
Clin Res Hepatol Gastroenterol. 2023;47:102114. PubMedAbstract available
MEURER A, Antoni C, Ebert MP, Trimborn A, et al Spontaneous bacterial peritonitis caused by Listeria monocytogenes: A rare
infection with very high leukocyte counts in ascitic fluid-case report and review
of the literature.
Clin Res Hepatol Gastroenterol. 2023;47:102130. PubMedAbstract available
April 2023
SASAKI M, Sato Y, Nakanuma Y An involvement of Hippo-yes-associated protein pathway in biliary epithelial
senescence in primary biliary cholangitis.
Clin Res Hepatol Gastroenterol. 2023;47:102106. PubMedAbstract available
March 2023
CAO L, Qu N, Wang X, Chen L, et al The function of long non-coding RNA in non-alcoholic fatty liver disease.
Clin Res Hepatol Gastroenterol. 2023;47:102095. PubMedAbstract available
February 2023
IANNONE G, Pompili E, Renzulli M, Caraceni P, et al A case of peri-stomal ectopic variceal bleeding in a patient with decompensated
cirrhosis treated with TIPS placement.
Clin Res Hepatol Gastroenterol. 2023 Feb 24:102098. PubMedAbstract available